Caredx Inc (CDNA): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Caredx Inc is $1.34B. A total of 1.82 million shares were traded on the day, compared to an average of 794.29K shares.

In the most recent transaction, Novack Jeffrey Adam sold 1,917 shares of CDNA for 26.00 per share on Dec 04 ’24. After the transaction, the Secretary and General Counsel now owns 110,237 company shares. In a previous transaction on Dec 04 ’24, Jeffrey Adam Novack bought 1,917 shares at 24.96 per share.

Among the insiders who sold shares, Maag Peter disposed of 5,000 shares on Nov 26 ’24 at a per-share price of $25.00. This resulted in the Director holding 330,024 shares of CDNA after the transaction. In another insider transaction, Novack Jeffrey Adam sold 5,534 shares at $21.77 per share on Nov 18 ’24. Company shares held by the Secretary and General Counsel now total 113,377.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CDNA has a high of $34.84 and a low of $7.42.

As of this writing, CDNA has an earnings estimate of $0.07 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.07 per share and a lower estimate of $0.07.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $5.15, while its Total Shareholder’s Equity was $465.88M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.00.

Most Popular

Related Posts